Obesity Does Not Protect Against Subarachnoid Haemorrhage
- byDoctor News Daily Team
- 06 August, 2025
- 0 Comments
- 0 Mins
 
                            
                                    Subarachnoid haemorrhage (SAH) is a life-threatening condition that kills, in contrast to other cerebrovascular disturbances, primarily healthy people of working age. Whereas smoking and high blood pressure are the most well-known risk factors associated with the condition, the role of many other lifestyle risk factors as causes of SAH has been unclear.
For a long time, obesity has been linked with a heightened risk of developing a number of diseases of the cardiovascular system, but findings pertaining to subarachnoid haemorrhage have been the opposite: the condition appears to occur at a lower frequency in overweight (body mass index 25–30) and obese individuals (body mass index >30) compared to underweight and normal-weight people. While the same observation has been repeatedly made in population-based follow-up studies, no explanation has been identified.
A study carried out by Finnish and Norwegian researchers published in the distinguished Stroke journal investigated whether obesity actually protects against subarachnoid haemorrhage. Unlike in prior studies, this was the first time that researchers comprehensively considered factors that may confound the findings, including people's smoking habits and the prevalence of hypertension.
The results were very clear: obesity does not protect against subarachnoid haemorrhage. According to Ilari Rautalin, the first author of the study, the findings provide a simple explanation of the previous observations.
"Smoking is much more common among underweight and normal-weight people than overweight and obese people. Neglecting to take smoking habits into account produces a false observation of subarachnoid haemorrhage occurring less often in obese people, since smoking is less common among them than others," explains Rautalin, MD, from the University of Helsinki.
A study based on a dataset of over 200,000 people
A research dataset containing follow-up data for more than 200,000 individuals collected over almost 50 years was utilised in the study. Miikka Korja, docent of neurosurgery and the principal investigator of the study, emphasises the significance of extensive and high-quality research datasets.
"This collaborative Nordic study serves, once again, as an excellent illustration of why studies on the risk factors associated with cerebral haemorrhage should be based on large and high-quality research datasets. Risk factors related to lifestyle are rarely independent of one another, which makes it challenging to investigate their interconnections. It's easy to draw incorrect conclusions on the independent effects of individual risk factors," notes Korja, head of section at the Department of Neurosurgery of the Helsinki University Hospital.
In conclusion, Rautalin and Korja emphasise that while the effect of obesity itself appears to be minor in connection with subarachnoid haemorrhage, many other adverse health effects caused by obesity should be taken into consideration. Therefore, the researchers recommend that the goal should continue to be to achieve and maintain normal weight, refrain from smoking as well as effectively prevent and treat hypertension.
https://www.ahajournals.org/doi/10.1161/STROKEAHA.121.034782
                                
    Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
    The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
    Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
    If you come across any inconsistencies, please reach out to us at 
    admin@doctornewsdaily.com.
    We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
    By using this website, you agree to our 
    Terms of Use, 
    Privacy Policy, and 
    Advertisement Policy.
    For further details, please review our 
    Full Disclaimer.
Tags:
Recent News
Merck Keytruda wins European Commission nod for lo...
- 30 October, 2025
UP NEET 2025 round 3 allotment results postponed
- 30 October, 2025
Achin Gupta to succeed Umang Vohra as Cipla MD, GC...
- 30 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
 
                     
                    
0 Comments
Post a comment
No comments yet. Be the first to comment!